High-dose-rate interstitial brachytherapy for a bulky sebaceous carcinoma of the eyelid: A case report

5Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

High-dose-rate interstitial brachytherapy (HDR-ISBT) achieved excellent local control of the bulky sebaceous carcinoma of the eyelid. However, we must pay attention to dose of eyelid and cornea about late toxicity of HDR-ISBT.

Cite

CITATION STYLE

APA

Takagawa, Y., Murakami, N., Suzuki, S., Matsumoto, F., Yoshimoto, S., & Itami, J. (2019). High-dose-rate interstitial brachytherapy for a bulky sebaceous carcinoma of the eyelid: A case report. Clinical Case Reports, 7(10), 1844–1848. https://doi.org/10.1002/ccr3.2360

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free